191 related articles for article (PubMed ID: 30585270)
21. Knockdown of tripartite motif 59 (TRIM59) inhibits tumor growth in prostate cancer.
Lin WY; Wang H; Song X; Zhang SX; Zhou PS; Sun JM; Li JS
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4864-4873. PubMed ID: 27981550
[TBL] [Abstract][Full Text] [Related]
22. The role of TRIM59 in immunity and immune-related diseases.
Jin Z; Chen T; Zhu Z; Xu B; Yan D
Int Rev Immunol; 2024; 43(1):33-40. PubMed ID: 35975813
[TBL] [Abstract][Full Text] [Related]
23. TRIM59 promotes osteosarcoma progression via activation of STAT3.
Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
[TBL] [Abstract][Full Text] [Related]
24. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
25. CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity.
Sang Y; Li Y; Zhang Y; Alvarez AA; Yu B; Zhang W; Hu B; Cheng SY; Feng H
Nat Commun; 2019 Sep; 10(1):4013. PubMed ID: 31488827
[TBL] [Abstract][Full Text] [Related]
26. TRIM59 promotes gefitinib resistance in EGFR mutant lung adenocarcinoma cells.
Cui Z; Liu Z; Zeng J; Zhang S; Chen L; Zhang G; Xu W; Song L; Guo X
Life Sci; 2019 May; 224():23-32. PubMed ID: 30902544
[TBL] [Abstract][Full Text] [Related]
27. LncRNA SNHG14 potentiates pancreatic cancer progression via modulation of annexin A2 expression by acting as a competing endogenous RNA for miR-613.
Deng PC; Chen WB; Cai HH; An Y; Wu XQ; Chen XM; Sun DL; Yang Y; Shi LQ; Yang Y
J Cell Mol Med; 2019 Nov; 23(11):7222-7232. PubMed ID: 31513352
[TBL] [Abstract][Full Text] [Related]
28. TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma.
Liang J; Xing D; Li Z; Shen J; Zhao H; Li S
Mol Med Rep; 2016 Jun; 13(6):5200-6. PubMed ID: 27121462
[TBL] [Abstract][Full Text] [Related]
29. TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway.
Tong X; Mu P; Zhang Y; Zhao J; Wang X
J Cell Physiol; 2020 Nov; 235(11):8236-8245. PubMed ID: 31951023
[TBL] [Abstract][Full Text] [Related]
30. TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.
Sang Y; Li Y; Song L; Alvarez AA; Zhang W; Lv D; Tang J; Liu F; Chang Z; Hatakeyama S; Hu B; Cheng SY; Feng H
Cancer Res; 2018 Apr; 78(7):1792-1804. PubMed ID: 29386185
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of TRIM59 for cancer patient survival: A systematic review and meta-analysis.
Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
Medicine (Baltimore); 2019 Nov; 98(48):e18024. PubMed ID: 31770215
[TBL] [Abstract][Full Text] [Related]
32. CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling.
Cui HY; Wang SJ; Miao JY; Fu ZG; Feng F; Wu J; Yang XM; Chen ZN; Jiang JL
Oncotarget; 2016 Feb; 7(5):5613-29. PubMed ID: 26716413
[TBL] [Abstract][Full Text] [Related]
33. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
[TBL] [Abstract][Full Text] [Related]
34. Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT.
Liu Y; Li H; Ban Z; Nai M; Yang L; Chen Y; Xu Y
Oncol Rep; 2017 Jun; 37(6):3643-3650. PubMed ID: 28440436
[TBL] [Abstract][Full Text] [Related]
35. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
Zhan W; Han T; Zhang C; Xie C; Gan M; Deng K; Fu M; Wang JB
PLoS One; 2015; 10(11):e0142596. PubMed ID: 26599082
[TBL] [Abstract][Full Text] [Related]
36. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
[TBL] [Abstract][Full Text] [Related]
37. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
38. Annexin A2 plays a critical role in epithelial ovarian cancer.
Deng Y; Chen C; Hua M; Xi Q; Liu R; Yang S; Liu J; Zhong J; Tang M; Lu S; Tang C; Wang Y
Arch Gynecol Obstet; 2015 Jul; 292(1):175-82. PubMed ID: 25547062
[TBL] [Abstract][Full Text] [Related]
39. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
[TBL] [Abstract][Full Text] [Related]
40. An TRIM59-CDK6 axis regulates growth and metastasis of lung cancer.
Geng B; Liang M; Qin L; Zhao W; Wang H; Wang L; Pan X; Chen X
J Cell Mol Med; 2019 Feb; 23(2):1458-1469. PubMed ID: 30515965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
